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SummAry
Aims of this prospective study were to evaluate the results of vocal fold structural fat grafting for glottic insufficiency and to compare the 
outcomes obtained in unilateral vocal fold paralysis (uVFP) and congenital or acquired soft tissue defects in vocal folds. Sixty-six consecu-
tive patients with breathy dysphonia, in 43 cases (aged 16-79 years) related to uVFP and in 23 cases (aged 16-67 years) related to vocal 
fold iatrogenic scar or sulcus vocalis, underwent autologous structural fat grafting into vocal folds. lipoaspirates were centrifuged at 1200 
g for 3 min to separate and remove blood, cell debris and the oily layer. The refined fat was injected under direct microlaryngoscopy in a 
multilayered way. The main outcome measures were grade, roughness, breathiness, asthenicity and strain (grBAS) perceptual evaluation, 
maximum phonation time (mPT), self-assessed Voice handicap index (Vhi), and voice acoustic analysis, considered pre-operatively and at 
3 and 6 months after fat grafting. After surgery, mPT, Vhi, g and B improved in both groups (p < 0.05). in particular, g and Vhi functional 
subscales showed a significantly greater decrease in patients with uVFP (p < 0.05). The acoustic variables improved significantly only 
in the uVFP group (p < 0.005). From 3 to 6 months postoperatively, most variables showed a trend with further improvement. Vocal fold 
structural fat grafting was significantly effective in treating glottic insufficiency due to uVFP or soft tissue defects. Perceptual, acoustic and 
subjective assessments confirmed that patients with uVFP had better outcomes than those with soft tissue defects.
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riASSunTo
Gli scopi di questo studio prospettico sono stati la valutazione multidimensionale dei risultati ottenuti con il trapianto di grasso autologo 
nelle corde vocali applicando la tecnica della lipostruttura, ed il confronto tra pazienti affetti da paralisi laringea monolaterale e difetti 
dei tessuti molli cordali, di natura congenita o acquisita. Sono stati studiati 66 pazienti consecutivi con insufficienza glottica dovuta in 43 
casi (età 16-79 anni) a paralisi laringea monolaterale e in 23 (età 16-67 anni) a lesioni cicatriziali iatrogene delle corde vocali o a sulcus 
glottidis. Il tessuto adiposo è stato prelevato mediante aspirazione a bassa pressione negativa ed il lipoaspirato è stato centrifugato a 
1200 g per 3 minuti per separare e rimuovere sangue, detriti cellulari e strato oleoso. I pazienti sono stati sottoposti all’iniezione di grasso 
purificato in una o in entrambe le corde vocali in microlaringoscopia diretta cercando di ottenere la diffusione in tutto lo spessore cordale. 
La valutazione dei risultati è stata eseguita mediante la scala percettiva (GRBAS), la misurazione del tempo massimo fonatorio (TMF), la 
somministrazione del questionario Voice Handicap Index (VHI) e l’analisi acustica della voce con MDVP. Per l’analisi statistica abbiamo 
considerato la valutazione pre-operatoria e quelle eseguite 3 e 6 mesi dopo l’intervento. Dopo l’intervento in entrambi i gruppi di pazienti 
è stato ottenuto un miglioramento significativo di TMF, VHI, e dei parametri G e B della scala GRBAS (p < 0,05). In particolare, G e la 
scala funzionale del VHI sono migliorati in modo più significativo nei pazienti con disfonia paralitica (p < 0,05). Le variabili acustiche 
sono migliorate solo nel gruppo delle disfonie paralitiche. Dai 3 ai 6 mesi dopo l’intervento è stato riscontrato un trend al miglioramento 
ulteriore in entrambi i gruppi di pazienti. In conclusione, l’iniezione di grasso autologo secondo il metodo della lipostruttura è significati-
vamente efficace nel trattamento dell’insufficienza glottica sia in caso di paralisi laringea monolaterale che di alterazione della struttura 
cordale di tipo congenito o acquisito. Tuttavia le valutazioni soggettiva, acustica e percettiva evidenziano risultati migliori nei pazienti 
affetti da disfonia paralitica. 
PArole ChiAVe: Lipostruttura • Paralisi laringea monolaterale • Incompetenza glottica • Cicatrice cordale • Sulcus glottidis
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Introduction
Breathy dysphonia can be a disabling condition that has 
an immense impact on the quality of life and negatively 
influences social and professional relationships. unilat-
eral vocal fold paralysis (uVFP) is a frequent cause of 
severe breathy dysphonia resulting from insufficient vocal 
fold adduction. The glottic air leak causes a poorly audi-
ble voice, respiratory fatigue on phonation and, in some 
cases, a swallowing impairment due to glottic sphincter 
dysfunction. Congenital or acquired tissue defects in the 
vocal folds may also severely alter voice production when 
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the rigidity in the superficial layers of the vocal fold caus-
es an impairment of the mucosal wave and consequent 
glottic insufficiency.
over the years, glottic insufficiency has been treated with 
vocal fold augmentation by injecting either non-reab-
sorbable implants, such as Teflon 1 or hydroxyapatite 2, 
or absorbable materials, such as collagen 3 or hyaluronan 
derivatives 4. Fat grafting in the vocal folds was first de-
scribed in the early 1990s. independently, mikaelian et 
al. 5 reported successful treatment of 3 patients while 
Brandenburg et al. 6 reported on 11 patients with laryngeal 
paralyses. Subsequently, several others reported their ex-
perience in using fat grafting to treat paralytic glottic in-
competence, with inconsistent results 7-11 that were mainly 
due to resorption.
The advent of the liposuction technique made autolo-
gous fat a readily available material to be harvested with 
a minimally invasive technique, and there has been a re-
newed interest in fat injections as a means of augment-
ing soft tissue defects. Clinical studies have shown that 
the key to improve grafted fat survival is to maximize the 
surface area of contact between fat parcels and recipient 
tissues 12.
Basic research over the past few years has shown that fat 
should no longer be considered as just an energy reservoir, 
but as a vital organ, the stromal vascular fraction of which 
contains a cell population with the typical features of 
mesenchymal stem cells 13. intense international research 
is investigating the potential of adipose-derived stem cells 
(AdSCs) to differentiate and regenerate 14 15, which are 
processes that might play a role in the effectiveness of vo-
cal fold lipoinjection 16.
Although autologous fat grafting is a straightforward pro-
cedure for vocal fold augmentation, consensus is lacking 
on the indications and choice of techniques. whereas nu-
merous reports refer to lipoinjection applied in clinical 
practice for vocal fold paralysis or paresis 5-9 17 18, fewer 
investigators have reported the results obtained in treating 
soft tissue defects 10 11 19-21. 
The present study was designed to analyze the outcomes 
of fat grafting in the treatment of breathy dysphonia and 
vocal fatigue due to glottic insufficiency and results ob-
tained were then compared with those in patients with 
uVFP and those with soft tissue defects in the vocal folds 
by means of perceptual, acoustic and patient self-assess-
ment. 
Patients and methods
Patients 
A series of 66 consecutive patients with breathy dysphonia 
were prospectively studied at our university hospital. of 
these, 43 (20 men and 23 women, mean age 51.02 ± 14.78 
years) had glottic insufficiency for uVFP due to thyroid-
ectomy (16 cases), cervical spine surgery (2), thoracic 
surgery (7), cranial base surgery (5), carotid endarterec-
tomy (2), neck trauma (2), guillain-Barré syndrome (1), 
diphtheria (1), or an unknown cause (7). The mean time 
elapsed from the onset of uVFP was 8.42 ± 12.80 years 
(median 1.5 years). in the remaining 23 patients (12 men 
and 11 women, 43.7 ± 15.18 years), glottic insufficiency 
was related to vocal fold soft tissue defects: iatrogenic vo-
cal fold scarring (10 cases) or bilateral sulcus vocalis (13). 
All patients had previously undergone extensive voice 
therapy without significant benefit.
The study was approved by the institutional review board 
of ospedale maggiore Policlinico. 
Surgical technique 
The procedure was performed with the patient under gen-
eral anaesthesia. The usual fat donor site was the lower 
abdomen, and in thin patients, the fat was harvested from 
the inner knee or the inner thigh. donor sites were in-
filtrated with lidocaine and epinephrine 1:100,000. Fatty 
tissue was harvested by liposuction under mild negative 
pressure using a 10 ml luer-lock syringe connected to a 
two-hole blunt cannula (2 mm diameter, 23 cm length). 
The lipoaspirate was processed according to the method 
described by Coleman 22, using centrifugation at 1200 g 
for 3 min to separate the different components into 3 lay-
ers: an oily upper layer of ruptured adipocytes, a middle 
layer of fat cells and a lower layer containing blood and 
lidocaine. The oily layer was withdrawn with a needle, the 
lower liquid layer was released removing the luer-lock 
plug, and the refined fat tissue was placed in the barrel 
of a pistol (medtronic, micro-France, mCl-55) with a 
19 gauge bayonet needle. Air exposure was minimized to 
avoid bacterial contamination 22.
Fat was injected under direct microlaryngoscopy into the 
defective vocal fold in a multilayered way to maximize 
the surface contact with the host tissue to enhance survival 
chances 23 24. The injection was performed slowly to avoid 
excessive pressure, and the needle was gently retracted to 
enhance diffusion. in patients with vocal fold paralysis, 
the first treated site was lateral to the vocal process to ob-
tain medialization, followed by the mid-third and anterior 
third of the paralyzed fold deep in the vocal muscle. in 
patients with glottic insufficiency due to soft tissue de-
fects, fat was injected first in the mid-fold, with other sites 
treated as needed. in cases with scars or sulci, the injec-
tion was performed also in the superficial layer to free the 
adherences and restore the gliding layer. The amount of 
injected fat ranged from 0.4 to 3 ml for each vocal fold. if 
only one vocal fold was treated, it was overinflated until 
its initial volume was subjectively judged to have been 
almost doubled (Fig. 1); in patients who received bilateral 
injections, only one fold was overcorrected.
intravenous clarithromycin 250 mg was given twice daily 
on the day of surgery, and oral clarithromycin 500 mg was 
given twice daily for the following 6 days. dexametha-
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sone sodium phosphate 8 mg was routinely administered 
intra-operatively to prevent oedema.
Fat was injected in the paralyzed vocal fold in all patients 
with uVFP; in 10 aphonic cases with severe glottic in-
competence, a smaller amount (0.4 - 1.2 ml) was also 
placed in the contralateral fold to enhance glottic closure. 
in the patients with soft tissue defects in the vocal folds, 
fat was injected on both sides in 19 cases and unilaterally 
in 4 cases. 
Methods of laryngeal and voice evaluation
The outcome measures considered in this study were 
gathered pre-operatively and at 3 and 6 months after 
lipoinjection. All patients underwent videolaryngostrobo-
scopy with a flexible fiberscope or a 70° rigid fiberoptic 
endoscope to document the site and severity of the glot-
tic gap and vocal fold vibration abnormalities, to plan the 
injection sites and to assess post-treatment changes ob-
jectively. 
glottic efficiency was tested with the maximum phona-
tion time (mPT) measured while subjects sustained the 
vowel /a/ at a comfortable pitch and loudness; 3 consecu-
tive trials were run, and the best one was considered. 
For perceptual voice evaluation, we used the grBAS 
scale 25, which subjectively scores the grade of dyspho-
nia (g), roughness (r), breathiness (B), asthenicity (A) 
and strain (S). The voice samples were computer-record-
ed using a dynamic microphone (model C 1000 S, AKg 
Acoustics gmbh, Vienna, Austria) at a constant distance 
of 5 cm from the patient’s mouth while the subject pro-
duced a sustained/a/, repeated single words and sentences, 
and continued a conversation. The recordings were subse-
quently evaluated by 3 experienced independent listeners 
and scored in the usual manner (0 = normal; 1 = slight 
disturbance; 2 = moderate disturbance; 3 = severe distur-
bance). The g, r and B scores were computed for out-
come evaluation. 
The Voice handicap index (Vhi) 26, a 30-item test divid-
ed into 3 subscales that measure the functional, physical 
and emotional features of the disability caused by voice 
impairment was used for patient self-assessment. The 
subscale scores ranged from 0 to 50, and the total ranged 
from 0 to 150, with a higher score indicating a greater 
degree of disability. 
Voice acoustic analysis data were analyzed with the multi 
dimensional Voice Programme (mdVP, Kay elemetrics 
Corp., lincoln Park, uSA): the sustained vowel /a/ was 
recorded. in our study, 5 variables were considered: jitter 
(Jitt%) and a coefficient of variation of fundamental fre-
quency (vF0) for short and middle term pitch perturbation 
analysis, shimmer (Shim%) and a coefficient of variation 
of amplitude (vAm) for short and middle term amplitude 
perturbation analysis, and noise to harmonic ratio (nhr). 
Acoustic analysis was feasible in 46 cases (28 uVFP pa-
tients and 18 of the soft tissue defects group), but in the 
remaining 20, the voice signal was too aperiodic to be 
analyzed.
Statistical analysis 
data are presented as the mean ± standard deviation (Sd). 
For the intergroup comparison of data gathered before 
surgery, the exact mann-whitney test was used for con-
tinuous variables, and the exact Fisher test was used for 
ordinal variables. The exact wilcoxon test was used to 
compare the data before surgery and after 3 and 6 months 
follow-up in each group. Two-sided exact tests were used, 
and p values of less than 0.05 were considered to be signif-
icant. A General Linear model (glm) for repeated meas-
ures was used to investigate changes in the primary out-
come variables of mPT, Jitt%, vF0, Shim%, vAm, nhr, 
grB, and Vhi from baseline and at 3 and 6 months after 
surgery and if the variations differed between the 2 groups 
of patients. All statistics were calculated using the Statis-
tical Package for the Social Sciences 17.0 for windows 
software package (SPSS inc, Chicago, il). 
Results
The 2 groups under study were similar as far as concerns 
the distributions of age and sex (p = ns), and at the base-
line evaluation, they differed only in the acoustic variable 
Jitt% (p = 0.035) and the perceptual voice measures of g 
(p = 0.003) and B (p = 0.004) of the grBAS scale, which 
were higher in the uVFP group than in the soft tissue de-
fects group. 
All patients had an uneventful post-operative course. 
none of them presented stridor at any time. no donor site 
morbidity occurred in any patient. 
Videostroboscopy defined the type and entity of the glot-
tic insufficiency and provided evidence that all treated 
patients achieved an improvement in glottic closure af-
ter surgery, although in most patients with soft tissue de-
fects, the mucosal wave showed a reduced amplitude. The 
videolaryngoscopic images obtained in a uVFP patient, 
before and after surgery, are shown in Figure 2; in this 
patient, at 6 months’ post-operatively, complete glottic 
closure was achieved. 
Fig. 1. Microlaryngoscopic view of vocal folds in a 67-year-old female af-
fected by post-thyroidectomy paralysis of left vocal fold for 72 months. A) 
Before fat grafting: hypotrophy of the paralyzed vocal fold is clearly visible. B) 
Augmentation obtained by fat grafting. 
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The glm analysis indicated significant improvements in 
the following outcome measures: mPT (p = 0.022), Vhi-
functional subscale (p = 0.002), Vhi- physical subscale 
(p < 0.001), Vhi- emotional subscale (p < 0.001), Vhi-
total (p < 0.001), g (p < 0.001) and B (p = 0.001) in both 
groups. For all these variables (Table i and Figures 3- 5), 
changes from baseline showed that the achieved improve-
ments were already significant at 3 months after surgery 
(mPT: p = 0.005, Vhi- functional subscale: p = 0.006, 
Vhi- physical subscale: p < 0.001, Vhi- emotional sub-
scale p = 0.006, Vhi-total: p < 0.001, g: p = 0.002, B: 
p < 0.001) and that they were maintained in both groups 
(all p = ns) during the subsequent follow-up (from 3 to 6 
months after surgery) (Table i). 
The glm analysis of deviance disclosed a greater reduc-
tion in the Vhi functional subscale in patients with uVFP 
than in those with soft tissue defects after 6 months of fol-
low-up (p = 0.034). no significant difference was found in 
the degrees of improvement between groups for mPT and 
total Vhi, although when follow-up ended, the patients 
with uVFP had higher mPT and lower Vhi scores than 
patients with vocal fold soft tissue defects. 
in both groups, both the mPT and total Vhi further im-
proved from 3 to 6 months postoperatively as clearly 
shown by the graphs in Figures 3-4, although this positive 
trend was not statistically significant.
The acoustic indices behaved differently in the 2 groups: 
only in the uVFP patients did the Jitt%, vF0, Shim% and 
nhr improve significantly (p = < 0.001, 0.001, 0.001, 
0.027, respectively) during the first 3 months of follow-
up; in the other group, the same variables remained sta-
tistically unchanged. Conversely, after the fat injection, 
vAm remained unchanged in both groups (p = ns).
The variable g (p = 0.014) improved in both groups, and 
no significant difference was found in the degree of im-
provement at 3 and 6 months between the 2 groups. nev-
ertheless, when follow-up ended, 38% of patients with 
uVFP had a normal voice and 52% had a slight voice 
disturbance according to grBAS evaluation, whereas no 
patients in the other group had a normal voice and 50% 
still manifested a moderate disturbance (see Fig. 5). 
The variable B behaved similarly to g. Although the base-
line values were worse in the uVFP group, a significant 
improvement occurred for both groups at 3 months after 
surgery (p < 0.001), and a further improvement, which 
was not statistically significant, was seen at the 6 month 
Fig. 2. A-B): Pre-operative videolaryngoscopy in a man with right UVFP for 
19 months: wide gap of glottic closure on phonation (B). C-D): At 3 months 
post-op, glottic gap is reduced. E-F): At 6 months: complete glottic closure 
is achieved (F).
Table I. Outcome variables assessed before surgery and at 3 and 6 months follow-up in the 43 patients with unilateral vocal fold paralysis (UVFP) and 23 
with vocal fold scarring. Data are displayed as mean ± standard deviation.
Unilateral vocal fold paralysis Vocal fold soft tissue defects
Before surgery After 3 months After 6 months Before surgery After 3 months After 6 months
Maximum phonation time 
(seconds)
7.38 ± 4.61 10.50 ± 5.39 13.00 ± 9.46 8.55 ± 3.98 10.69 ± 4.03 11.73 ± 4.63
Variation coefficient of fundamental 
frequency
5.09 ± 4.55 2.21 ± 1.40 1.81 ± 1.24 4.56 ± 6.21 8.27 ± 12.37 3.45 ± 2.07
Jitter (%) 5.28 ± 5.35 1.98 ± 1.63 1.79 ± 1.53 3.26 ± 3.96 3.10 ± 2.05 3.08 ± 1.32
Variation coefficient of amplitude 15.18 ± 10.38 14.41 ± 10.60 6.80 ± 4.86 9.06 ± 5.47 11.39 ± 11.46 12.04 ± 7.75
Shimmer (%) 9.02 ± 8.65 5.49 ± 3.23 4.96 ± 3.41 7.55 ± 6.07 7.85 ± 6.33 7.93 ± 2.67
Noise to harmonic ratio (%) 1.08 ± 3.53 0.16 ± 0.06 0.14 ± 0.04 1.42 ± 4.09 1.01 ± 2.37 1.07 ± 0.06
VHI - functional subscale 25.50 ± 10.21 11.83 ± 6.83 9.33 ± 5.79 17.25 ± 9.08 15.50 ± 6.74 13.25 ± 7.69
VHI - physical subscale 25.92 ± 9.60 10.08 ± 6.11 10.83 ± 6.38 27.13 ± 8.77 16.13 ± 4.19 15.25 ± 6.02
VHI - emotional subscale 17.21 ± 10.05 9.50 ± 6.72 8.50 ± 7.97 20.83 ± 10.02 10.00 ± 8.19 5.88 ± 3.60
VHI – total 72.25 ± 25.07 31.42 ± 13.93 28.67 ± 13.36 58.00 ± 24.36 40.38 ± 17.00 34.38 ± 14.36
A B
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evaluation (Fig. 5). For the variable r, only the uVFP pa-
tients significantly improved at 3 and 6 months after sur-
gery (p = 0.002), while for the soft tissue defects patients, 
the improvement was borderline (p = 0.054).
Discussion
The reported results demonstrate that structural fat graft-
ing is an effective technique for vocal fold augmentation 
to treat breathy dysphonia and vocal fatigue due to glottic 
insufficiency. All patients underwent vocal fold fat injec-
tion according to the technique described by Coleman 22 24 
for fat processing and refinement. A crucial factor in al-
lowing the grafted fat to survive to ensure stable results 
over time is the modality of fat handling for minimizing 
the resorption rate. The variability in results reported in 
the literature with vocal fold lipoinjection might depend 
on the various techniques applied 8 9 27.
in our case series, another technical point that probably 
enhanced the voice results was that in 10 of the 43 patients 
with uVFP, all of whom had particularly severe glottic 
insufficiency, we also injected the normal moving vocal 
fold. 
in the patients with uVFP and those with soft tissue de-
fects, the primary outcome measures of mPT, grB and 
Vhi scores improved significantly after lipoinjection, 
while the acoustic indices significantly improved after 
surgery only in patients with uVFP. This was an expected 
finding considering the severe vibratory impairment typi-
cally found in patients with defective vocal fold soft tis-
sues. The grade of dysphonia evaluated by the grBAS 
scale and the Vhi functional subscale also improved more 
in the uVFP group than in the soft tissue defects group. 
interestingly, maximum phonation time was longer, 
though not significantly, at 6 months postoperatively than 
at 3 months, especially in patients with uVFP, indicating 
that the glottic closure progressively improved over time 
(Fig. 3). Further improvement at the 6-month follow-up 
was also found for the Vhi scores and for the variables 
g and B in both groups (Figs. 4, 5) and for the acoustic 
parameters in the uVFP group only (Table i). 
The multidimensional approach we used to assess our 
patients’ outcome provided reliable data and confirmed 
previous reports that paralytic dysphonia due to uVFP 
has a more favourable prognosis than soft tissue defects 
in the vocal folds 28. our finding that the results differed 
in the 2 groups of patients statistically confirmed that 
the aetiology of glottic insufficiency is a critical factor 
for prognosis when performing injection laryngoplasty. 
in patients with uVFP, the anatomy of the cover is pre-
served, and an efficient vocal fold vibration can be re-
stored if augmentation closes the phonatory glottic gap. 
Conversely, vocal fold scarring and congenital anoma-
Fig. 5. Distribution of dysphonia grade (G) and breathiness (B) in unilateral 
vocal fold paralyses (upper row) and vocal fold soft tissue defects (lower row) 
before surgery, and 3 and 6 months post-operatively.
Fig. 3. Maximun phonation time (in seconds) in unilateral vocal fold paraly-
sis (UVFP) and soft tissue defects groups. 
Fig. 4. Total Voice Handicap Index (VHI) scores in the two groups of pa-
tients under study before vocal fold fat injection, and 3 and 6 months post-
operatively.
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lies such as sulcus vocalis can cause stiffness in the glid-
ing tissue in the vocal fold “cover” 29 and consequently 
reduce the amplitude of the mucosal wave. An anatomi-
cal impairment of the vocal fold gliding cover is a chal-
lenging condition to treat because restoring the missing 
or compromised lamina propria remains one of the main 
surgical dilemmas in vocal fold microsurgery 28. in the 
case of discontinuity of the lamina propria, vocal fold 
augmentation may reduce the phonatory gap and the air 
leak and can partially restore the viscoelastic proper-
ties of the glottic vibrator. indeed, in our series, surgery 
reduced the phonatory gap in all patients, although it 
failed to normalize the mucosal wave amplitude if the 
soft tissue defects were present. in their study, Chan and 
Titze 30 demonstrated that the viscosity of fat is simi-
lar to the extracellular matrix in reinke’s space; hence, 
if fat is injected also in the vocal fold cover, vibration 
should remain unimpaired. This represents an impor-
tant point, as the currently available biomaterials do not 
have rheologic properties adequate to replace the lamina 
propria 31. moreover, non-reabsorbable implants, such 
as Teflon and silicone, can migrate and give rise to for-
eign body reactions 32, and biomaterials, such as colla-
gen, can cause delayed hypersensitivity reactions 33 and 
vocal fold stiffness from fibrosis 34. Autogenous fat is 
non-invasively obtained by liposuction, and it is soft and 
easily diffuses in the multiple layers of the vocal fold. it 
is a vital “filler”, and the recent studies highlighting the 
presence of pluripotent stem cells in its stromal vascular 
fraction support the regenerative potential of adipose tis-
sue for permanently augmenting defective vocal folds 16. 
The positive trend over time in the main outcome meas-
ures in our study seems to confirm that vocal fold tissues 
continue to improve even 3 months after lipoinjection 
and supports the hypothesis of a regenerative role played 
by the adipose derived stem cells.
In conclusion, vocal fold structural fat grafting is a 
straightforward and minimally invasive procedure for the 
rehabilitation of dysphonia in cases of glottic insufficien-
cy, and although UVFP has a more favourable prognosis, 
patients with vocal fold soft tissue defects can also expect 
a significant improvement.
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